Press Release: GSK : Public Communication - Health Canada Endorsed Important Safety Information on ARZERRA™ (ofatumumab)

Subject: ARZERRA™ (ofatumumab) - Fatal Infusion Reaction in a patient with Chronic Lymphocytic Leukemia (CLL) MISSISSAUGA, ON, Aug. 6, 2014 /CNW/ - GlaxoSmithKline Inc., in consultation with He...